Fosaprepitant
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Fosaprepitant
Description :
Fosaprepitant (L-785298) is a proagent of Aprepitant (HY-10052) . Fosaprepitant is a neurokinin-1 receptor antagonist, which is development for the prevention of chemotherapy-induced nausea and vomiting (CINV) [1].Product Name Alternative :
L-758298UNSPSC :
12352005Hazard Statement :
H302-H315-H319-H335Target :
Neurokinin ReceptorType :
Reference compoundRelated Pathways :
GPCR/G Protein; Neuronal SignalingApplications :
Metabolism-protein/nucleotide metabolismField of Research :
Neurological Disease; Endocrinology; CancerAssay Protocol :
https://www.medchemexpress.com/Fosaprepitant.htmlSolubility :
10 mM in DMSOSmiles :
O=C1N=C(CN2[C@@H](C3=CC=C(F)C=C3)[C@@H](O[C@H](C)C4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4)OCC2)NN1P(O)(O)=OMolecular Formula :
C23H22F7N4O6PMolecular Weight :
614.41Precautions :
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501References & Citations :
[1]Pranav Prasoon, et al. Role of fosaprepitant, a neurokinin Type 1 receptor antagonist, in morphine-induced antinociception in rats. Indian J Pharmacol. 2016 Jul-Aug; 48 (4) : 394-398.Shipping Conditions :
Room temperatureScientific Category :
Reference compound1Clinical Information :
LaunchedCitation 01 :
Cancer Biol Ther. 2019;20 (5) :653-665.|Acta Pharmacol Sin. 2025 Sep 10.|New J Chem. 29th November 2021.CAS Number :
[172673-20-0]

